Do not initiate Advair HFA with acutely deteriorating asthma; use in this setting is inappropriate. Not for relief of acute symptoms; acute symptoms should be treated with inhaled short-acting ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is ... double the dose of their inhaled corticosteroid ...

A Minnesota mom will spend less than four years in prison after pleading guilty to manslaughter after she and her husband ...

Do not initiate in rapidly or acutely deteriorating COPD or asthma. Not for use with other long-acting β 2-agonists. Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2-agonist ...

Approved in asthma and chronic obstructive pulmonary ... which prompted an amendment to the label for certain inhaled corticosteroids, including Advair and generics. The approval will also be ...

Teva has launched new digital inhaler and drug ... s blockbuster inhaler Advair (fluticasone+salmeterol). The competition for the product approved in asthma and COPD had been delayed for years ...

The U.S. Food and Drug Administration has updated the product labels for three widely known asthma drugs ... be the powerful bronchodilator medicines Advair and Serevent, made by GlaxoSmithKline ...

Medically reviewed by Jurairat J. Molina, MD HFA-based metered-dose inhalers (MDIs) contain a propellant to deliver the ...